Get the Stockscreener App
1.0299
6.48%
-0.0501
180 Life Sciences Corp stock is traded at $1.0299, with a volume of 58,255.
It is down -6.48% in the last 24 hours and down -24.06% over the past month.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
See More
Previous Close:
$1.08
Open:
$1.08
24h Volume:
58,255
Relative Volume:
0.15
Market Cap:
$3.21M
Revenue:
-
Net Income/Loss:
$-3.12M
P/E Ratio:
-0.2139
EPS:
-4.8149
Net Cash Flow:
$-2.69M
1W Performance:
-14.41%
1M Performance:
-24.06%
6M Performance:
-44.20%
1Y Performance:
-71.79%
1-Day Range:
$0.9949
$1.08
1-Week Range:
$0.9949
$1.19
52-Week Range:
$0.9949
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
Compare ATNF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
1.0299 | 3.21M | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
507.77 | 130.68B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
679.18 | 74.97B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.43 | 36.08B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.07 | 31.19B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.51 | 27.56B | 3.32B | -860.46M | -1.04B | -8.32 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
ATNF stock touches 52-week low at $1.1 amid market fluctuations - Investing.com
Contract wins and repeat business fuel progress at life sciences company - The Business Desk
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Down 50.4% in February - Defense World
Short Interest in ArrowMark Financial Corp. (NASDAQ:BANX) Expands By 62.6% - Defense World
American Rebel Holdings, Inc. (NASDAQ:AREB) Sees Large Growth in Short Interest - Defense World
ATNF stock touches 52-week low at $1.14 amid market shifts - Investing.com India
Global Dupuytrens Disease Market Deep Research 2025-2032 | Endo - openPR
180 Life Sciences Appoints New Chief Accounting Officer - TipRanks
180 Life Sciences (NASDAQ:ATNF) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
TURN180 Degree Capital Corp Latest Stock News & Market Updates - StockTitan
180 Life Sciences Corp. modifies former CEO's exit terms - MSN
180 Life Sciences Corp. modifies former CEO's exit terms By Investing.com - Investing.com Canada
180 Life Sciences Appoints New CEO Amid Leadership Changes - TipRanks
Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan
180 Life Sciences (NASDAQ:ATNF) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire
Sai Life Sciences Shares Continue To Decline, Slumps Over 11% In A Week Despite Expansion Plans - Free Press Journal
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration - ACCESS Newswire
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules - ACCESS Newswire
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire
Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why - Nasdaq
180 Life Sciences (NASDAQ:ATNF) Earns Sell (E+) Rating from Weiss Ratings - Defense World
Athena Bitcoin Global Announces Appointment of Omar Jimenez as Chief Financial Officer - ACCESS Newswire
Pre-market Movers: AVGR, TIVC, ATNF, SLGL... - RTTNews
Here are 71 Mass. life science firms presenting at J.P. Morgan - The Business Journals
180 Life Sciences to Raise $2.9M as It Shifts Focus to iGaming - GamblingNews.com
180 Life Sciences Corp. expands stock incentive plan - Investing.com India
180 Life Sciences Doubles Down on iGaming with $2.9M Fundraising Effort - Real Money Gambling News
180 Life Sciences Announces Key Proposals and Director Elections - TipRanks
US biotech firm announces $2.9m stock offering amid pivot to iGaming - NEXT.io
Stock offering fuels company's leap to iGaming - Silicon Valley Business Journal
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under NASDAQ Rules - Marketscreener.com
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Expands By 148.1% - Defense World
Stock market news: Siyata Mobile -90.00%, PainReform -29.18% among biggest losers during mid day trading - Business Upturn
Stock market today: Siyata Mobile -89.40%, Millennium Group International -27.94% among biggest losers in early trading - Business Upturn
180 Life Sciences announces $2.9 million securities offering - Investing.com
180 Life Sciences (ATNF) Raises $2.9M in Direct Offering, Pivots to Entertainment & iGaming - StockTitan
Alector (ALEC) Stock Dips Amid Mixed Analyst Ratings - GuruFocus.com
180 Life Sciences Corp. Announces Board Changes - Marketscreener.com
180 Life Sciences Corp. Announces Executive Changes - Marketscreener.com
180 Life Sciences Corp. announces CFO resignation - Investing.com India
180 Life Sciences CFO Omar Jimenez Resigns - TipRanks
180 Life Sciences Corp. announces CFO resignation By Investing.com - Investing.com UK
XGEN Venture Announces Final Closing of €180M ($190M) Life Sciences Fund - Yahoo Finance
Sai Life Sciences IPO listing date: Check objectives, subscription and other key details ahead of debut - Upstox
180 Life Sciences Regains Nasdaq Compliance, Advances Strategic Pivot into iGaming Tech - StockTitan
Sai Life Sciences IPO analysis - Value Research Online
ChromaDex maintains Buy rating on recent agreement - Investing.com
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):